TRxADE Health Inc reports results for the quarter ended in June - Earnings Summary

Scienture Holdings

18/08/2023 22:44

* TRxADE Health Inc  MEDS.OQ  reported a quarterly adjusted
loss
of $2.90​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 75 cents per
share.
    * Revenue fell 31.3% to $2.25 million from a year ago;
analysts
expected $2.06 million. 
    * TRxADE Health Inc's reported EPS for the quarter was a
loss of
$2.90​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * TRxADE Health Inc shares had fallen by 45.7% this
quarter and
gained 17.2% so far this year.
    * The company reported a quarterly loss of $1.98 million.
    * Wall Street's median 12-month price target for TRxADE
Health Inc
is $6.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 18 at 09:44 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.75          -2.90          Missed
 Mar. 31 2023      -0.45          -1.05          Missed
 Dec. 31 2022      -0.97          -0.15          Beat
 Sep. 30 2022      -1.80          -0.90          Beat